jump to content jump to footer

Categories:

New iRECIST whitepaper published
We are happy to present our newly published whitepaper on iRECIST and its application. This is available here on our homepage as well as on…
4 Questions – 4 Answers // Imaging in Clinical Trials
Mint Medical, Inc. Vice President of Clinical Trials, Kelie Luby Discusses Advances in Imaging Analysis in Clinical Trials and What’s Next for Mint…
Joint partnership between Mint Medical and Siemens Healthineers syngo.via
Siemens Healthineers and Mint Medical joined forces to accelerate imaging and result reporting software availability in hospitals when and where it is…
Mint-Data for Personalized Medicine at Cancer Center in Tübingen/Germany
Compiling structured real-world-data from different medical disciplines, such as molecular genetics, laboratory medicine, pathology or radiology, to…
Number of Clinical Trials in Oncology has increased strongly during the last 10 years
Cancer cases and cancer related deaths continue to increase globally. While new cancer therapies are being identified offering new options for…
New TNM- and RADS-Classification in mint Lesion
With the aid of various clinical reading templates, mint Lesion provides context-specific support in the application of established radiological…
New mint Lesion 3.4 Software presented at RSNA 2017
With mint Lesion 3.4, reproducible assessment and structured reporting of significant image observations are easier than ever. Numerous improvements…
ESOI/EORTC Workshop in Barcelona: Participants practice tumour response assessment using mint Lesion™
The autumn workshop of the European Society of Oncological Imaging (ESOI) and the European Organisation for Research and Treatment of Cancer (EORTC)…